Clinical Trial Update: Denosumab Versus Bisphosphonates (Alendronate) in GIOP [Phase 4]

View source ↗

Summary

Phase 4 trial comparing denosumab to alendronate in osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• alendronate (alendronate)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED